Company Analysis

Spyre Therapeutics, Inc. (SYRE)

Nasdaq: SYRE · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2015
Grade5.2
◀ Past 2.7● Present 6.0▶ Future 6.2
5 est.

Who runs Spyre Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Turtle Cameron
Chief Executive Officer. First filing Jun 2023, latest Oct 2, 2026, 12 filings in all.
Officers reporting now
4
of 13 people with a filing in the last fifteen months
Directors reporting now
9
49 people on the record since 2016
Officerssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Turtle CameronChief Executive OfficerJun 2023Oct 2, 202640 · $11.4M
Burrows Scott LChief Financial OfficerSep 2023Oct 2, 202626 · $9.1M
King-Jones HeidySee RemarksSep 2023Oct 2, 202610 · $5.1M
Sloan SheldonChief Medical OfficerOct 2024Jul 2, 202611 · $7.4M
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Albers Jeffrey W.directorNov 2023Aug 10, 20263 · $2.4M
Fairmount Funds Management LLCdirectorJun 2023Jun 23, 20261 · $400M
Fairmount Healthcare Fund II L.P.directorJun 2023Jun 23, 2026none
Harwin Peter EvandirectorJun 2023Jun 23, 2026none
Henderson Michael ThomasdirectorJun 2023Jun 23, 20265 · $8.0M
Kiselak TomasdirectorJun 2023Jun 23, 2026none
Mckenna Mark C.directorFeb 2024May 29, 2026none
Milligan SandradirectorMay 2024May 29, 2026none
Stelzer LauriedirectorNov 2023May 29, 2026none
Earlier names on the record44, newest filing first
Fairmount Healthcare Co-Invest L.P. · director · last filing Dec 2023Fairmount Healthcare Fund L.P. · director · last filing Dec 2023Alspaugh Jonathan · officer · last filing Jun 2023Cox Russell J. · director · last filing Jun 2023Lawton Alison Frances · director · last filing Jun 2023Magovcevic-Liebisch Ivana · director · last filing Jun 2023Smith Hunter C · director · last filing Jun 2023Hanley Jr. Michael Conick · officer · last filing Feb 2023Neuman Linda L · officer · last filing Feb 2023Kastenmayer James Paul · officer · last filing Feb 2023Goldberg Jeff Marc · officer · last filing Dec 2022Sloan Leslie · officer · last filing Aug 2022Souza Marcio · director · last filing Aug 2022Lawlis V Bryan · director · last filing Jun 2022Mahatme Sandesh · director · last filing Jun 2022Shanafelt Armen · director · last filing Jun 2022Quinn Anthony · officer · last filing Mar 2022Weber Steven · officer · last filing Feb 2022667, L.P. · director · last filing Jun 2021Baker Bros. Advisors (Gp) LLC · director · last filing Jun 2021Baker Bros. Advisors LP · director · last filing Jun 2021Baker Brothers Life Sciences LP · director · last filing Jun 2021Baker Felix · director · last filing Jun 2021Baker Julian · director · last filing Jun 2021Brownstein Sara · director · last filing Feb 2021Bruhn Suzanne Louise · director · last filing Jun 2020York Charles N II · officer · last filing Feb 2020Rao Madduri Ravin · officer · last filing Feb 2020Schuchart Aaron · officer · last filing Mar 2019Wooldridge James · officer · last filing Mar 2019Georgiou George · director · last filing Aug 2018Novartis AG · 10% owner · last filing May 2018Novartis Bioventures Ltd · 10% owner · last filing May 2018Rowlinson Scott W · officer · last filing Aug 2017Tyler Joseph E · officer · last filing Aug 2017Lowe David George · officer · last filing Mar 2017Hebel Henry · officer · last filing Mar 2017Isaly Samuel D · 10% owner · last filing Feb 2017Orbimed Advisors LLC · 10% owner · last filing Feb 2017Orbimed Capital Gp V LLC · 10% owner · last filing Feb 2017Rojas-Caro Sandra · officer · last filing May 2016Lilly Eli & Co · 10% owner · last filing Apr 2016Lilly Ventures Fund I LLC · 10% owner · last filing Apr 2016Torres S. Edward · 10% owner · last filing Apr 2016

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SYRE · research, not advice